Recent research suggests a potential link between Alzheimer's disease and impaired brain energy metabolism. Creatine supplementation has emerged as a promising strategy to address this issue, as it can boost brain ATP levels and is capable of crossing the blood-brain barrier. An eight-week pilot study indicated that individuals with Alzheimer's showed increased brain creatine levels and improvements in cognitive functions after creatine monohydrate supplementation. While early findings are optimistic, further large-scale trials are necessary to confirm these benefits and understand the therapeutic mechanisms involved.
Creatine supplementation appears to enhance brain energy metabolism, potentially providing a therapeutic avenue for conditions like Alzheimer's with a focus on cognitive improvement.
An eight-week pilot study indicated that creatine monohydrate supplementation resulted in increased brain creatine levels and improved cognitive performance in individuals with Alzheimer's.
Collection
[
|
...
]